Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON20089
NL-OMON20089CompletedNot Applicable

The effect of azithromicin ophthalmic solution on symptoms, signs, and markers of inflammation in patients with blepharitis.

Not provided0 sites30 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Opitz DL, Tyler KF. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis. Clin Exp Optom. 2011 Mar;94(2):200-6.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1. Symptoms of blepharitis;
  • •2. HLA-DR > 15% on conjunctival cells;

Exclusion Criteria

  • •1. Glaucoma;
  • •2. Ocular surface infections;

Investigators

Sponsor
Not provided

Similar Trials

Completed
Phase 2
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)Blepharitis
NCT00894530Merck Sharp & Dohme LLC314
Completed
Phase 2
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment PeriodBlepharitis
NCT00892970Merck Sharp & Dohme LLC313
Active, not recruiting
Not Applicable
Study to Evaluate the Potential of Azithromycin to Cause Eye Problems in Childre
EUCTR2016-001119-19-Outside-EU/EEAPfizer Inc.30
Completed
Not Applicable
The efficacy of azithromycin eye drops on the findings around the eyelids of patients with blepharitisblepharitis
JPRN-UMIN000044348Shimazaki eye clinic/Tokyo Dental College Ichikawa General Hospital30
Completed
Phase 4
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye DiseaseDry Eye Disease
NCT01014078Merck Sharp & Dohme LLC112